Breaking News Instant updates and real-time market news.

QCOM

Qualcomm

$79.09 /

+4.84 (+6.52%)

, INTC

Intel

$58.57 /

+2.17 (+3.85%)

07:35
04/18/19
04/18
07:35
04/18/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Wednesday in Qualcomm (QCOM), Intel (INTC), Freeport McMoRan (FCX), US Steel (X), Salesforce (CRM), Marvell (MRVL), Harley Davidson (HOG), Unum Group (UNM), Intra Cellular Therapies (ITCI), and Endurance (EIGI).

QCOM

Qualcomm

$79.09 /

+4.84 (+6.52%)

INTC

Intel

$58.57 /

+2.17 (+3.85%)

FCX

Freeport McMoRan

$14.18 /

+0.04 (+0.28%)

X

U.S. Steel

$16.66 /

-0.1 (-0.60%)

CRM

Salesforce

$155.31 /

-3.37 (-2.12%)

MRVL

Marvell

$24.87 /

+0.86 (+3.58%)

HOG

Harley-Davidson

$41.05 /

+0.28 (+0.69%)

UNM

Unum Group

$37.41 /

-0.12 (-0.32%)

ITCI

Intra-Cellular

$12.17 /

-0.52 (-4.10%)

EIGI

Endurance

$6.30 /

-0.2 (-3.08%)

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 16

    May

  • 11

    Jun

  • 23

    Jun

  • 27

    Sep

QCOM Qualcomm
$79.09 /

+4.84 (+6.52%)

04/18/19 DZ Bank
Qualcomm upgraded to Buy from Hold at DZ Bank
04/17/19
Fly Intel: Top five analyst upgrades
04/17/19 Wells Fargo
Intel exiting 5G smartphone modem business 'a positive,' says Wells Fargo
04/17/19
Qualcomm upgraded to Outperform following Apple settlement at Evercore ISI
INTC Intel
$58.57 /

+2.17 (+3.85%)

04/17/19 Baird
Lattice competitive landscape unchanged by Intel deal, says Baird
04/17/19 KeyBanc
Intel 5G modem challenges a key factor leading to Apple settlement, says KeyBanc
04/17/19 KeyBanc
Intel's plans to exit 5G Modem business not impacting 2019 outlook, says KeyBanc
FCX Freeport McMoRan
$14.18 /

+0.04 (+0.28%)

03/25/19 Jefferies
Jefferies sees 'significant trapped value' in shares of Freeport McMoRan
02/19/19
Fly Intel: Top five analyst upgrades
02/19/19 Citi
Freeport McMoRan upgraded to Buy from Neutral at Citi
02/13/19
Fly Intel: Top five analyst upgrades
X U.S. Steel
$16.66 /

-0.1 (-0.60%)

04/11/19
Fly Intel: Top five analyst downgrades
04/11/19 BofA
BofA double downgrades U.S. Steel to Underperform on worse U.S. conditions
04/11/19 BofA
U.S. Steel downgraded to Underperform from Buy at BofA/Merrill
04/09/19
Fly Intel: Top five analyst downgrades
CRM Salesforce
$155.31 /

-3.37 (-2.12%)

04/16/19 DA Davidson
Blackbaud under threat from Salesforce nonprofit investment, says DA Davidson
04/16/19 Jefferies
Salesforce remains a top large cap pick at Jefferies
04/09/19 Nomura Instinet
Nomura Instinet starts 'true disruptor' Tesla with Neutral rating, $300 target
04/05/19 Oppenheimer
Microsoft well positioned for digital transformations, says Oppenheimer
MRVL Marvell
$24.87 /

+0.86 (+3.58%)

04/17/19 Citi
Marvell price target raised to $28 from $22 at Citi
03/29/19 Mizuho
Xilinx price target raised to $140 from $107 at Mizuho
03/08/19 Craig-Hallum
Marvell shares fully valued at current levels, says Craig-Hallum
03/08/19 Oppenheimer
Oppenheimer says structural bull thesis on Marvell 'intact' after Q4 results
HOG Harley-Davidson
$41.05 /

+0.28 (+0.69%)

04/08/19 Wells Fargo
Harley-Davidson risk/reward less attractive at current levels, says Wells Fargo
04/08/19 Wells Fargo
Harley-Davidson downgraded to Market Perform from Outperform at Wells Fargo
04/03/19 Longbow
Polaris Industries estimates cut after dealer checks at Longbow
03/21/19 UBS
Harley-Davidson likely lost market share in past two months, says UBS
UNM Unum Group
$37.41 /

-0.12 (-0.32%)

01/09/19 Barclays
Barclays downgrades Life Insurance sector to Neutral from Positive
08/10/18 Barclays
Barclays double downgrades Brighthouse to Underweight on lack of catalysts
06/12/18 Citi
Unum Group price target lowered to $44 from $52 at Citi
05/03/18 RBC Capital
Unum Group price target lowered to $44 from $54 at RBC Capital
ITCI Intra-Cellular
$12.17 /

-0.52 (-4.10%)

12/12/18
Intra-Cellular price target raised to $37 from $35 at RBC Capital
12/12/18 Canaccord
Intra-Cellular's NDA acceptance puts some investors fears to bed, says Canaccord
11/13/18 SVB Leerink
Intra-Cellular initiated with an Outperform at Leerink
08/23/18 Cantor Fitzgerald
Intra-Cellular transferred with an Overweight at Cantor Fitzgerald
EIGI Endurance
$6.30 /

-0.2 (-3.08%)

03/27/19 Goldman Sachs
Endurance upgraded to Neutral from Sell at Goldman Sachs
01/09/19 Jefferies
Jefferies says be selective in Internet, cuts targets on Snap and Facebook
11/07/18 Oppenheimer
Endurance downgraded to Perform from Outperform at Oppenheimer
05/07/18 Jefferies
GoDaddy price target raised to $76 from $66 at Jefferies

TODAY'S FREE FLY STORIES

Options
Largest borrow rate increases among liquid names » 08:45
07/13/20
07/13
08:45
07/13/20
08:45
VAL

Valaris

$0.60 /

+0.0396 (+7.08%)

, BCLI

BrainStorm

$13.29 /

+0.14 (+1.06%)

, ZYNE

Zynerba

$3.78 /

+0.31 (+8.93%)

, ASHR

X-trackers Harvest CSI 300

$34.48 /

-0.445 (-1.27%)

, HTZ

Hertz

$1.46 /

+0.01 (+0.69%)

, NE

Noble Corp.

$0.29 /

+0.0088 (+3.12%)

, MVIS

MicroVision

$1.50 /

+0.01 (+0.67%)

, ACB

Aurora Cannabis

$12.00 /

+0.22 (+1.87%)

, VSTM

Verastem

$1.45 /

-0.005 (-0.34%)

, AXDX

Accelerate Diagnostics

$16.81 /

+0.2 (+1.20%)

Latest data shows the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VAL Valaris
$0.60 /

+0.0396 (+7.08%)

BCLI BrainStorm
$13.29 /

+0.14 (+1.06%)

ZYNE Zynerba
$3.78 /

+0.31 (+8.93%)

HTZ Hertz
$1.46 /

+0.01 (+0.69%)

NE Noble Corp.
$0.29 /

+0.0088 (+3.12%)

MVIS MicroVision
$1.50 /

+0.01 (+0.67%)

ACB Aurora Cannabis
$12.00 /

+0.22 (+1.87%)

VSTM Verastem
$1.45 /

-0.005 (-0.34%)

AXDX Accelerate Diagnostics
$16.81 /

+0.2 (+1.20%)

VAL Valaris
$0.60 /

+0.0396 (+7.08%)

05/13/20 Credit Suisse
Valaris downgraded to Underperform from Neutral at Credit Suisse
04/21/20 RBC Capital
Valaris downgraded to Underperform from Sector Perform at RBC Capital
04/21/20 RBC Capital
Valaris downgraded to Underperform from Sector Perform at RBC Capital
03/20/20 Credit Suisse
Valaris downgraded to Neutral from Outperform at Credit Suisse
BCLI BrainStorm
$13.29 /

+0.14 (+1.06%)

07/08/20 Maxim
BrainStorm price target raised to $20 from $9 at Maxim
ZYNE Zynerba
$3.78 /

+0.31 (+8.93%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
ASHR X-trackers Harvest CSI 300
$34.48 /

-0.445 (-1.27%)

HTZ Hertz
$1.46 /

+0.01 (+0.69%)

06/24/20 Jefferies
CarMax, AutoNation could be eyeing Hertz in bankruptcy, says Jefferies
05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
NE Noble Corp.
$0.29 /

+0.0088 (+3.12%)

05/13/20 Credit Suisse
Noble Corp. downgraded to Underperform from Neutral at Credit Suisse
04/21/20 RBC Capital
Noble Corp. downgraded to Underperform from Sector Perform at RBC Capital
03/17/20 Capital One
Noble Corp. downgraded to Underweight from Equalweight at Capital One
03/13/20 Wells Fargo
Drillers downgraded at Wells Fargo on recent sell off in commodity prices
MVIS MicroVision
$1.50 /

+0.01 (+0.67%)

05/06/20 Craig-Hallum
MicroVision rise driven by Microsoft speculation, says Craig-Hallum
02/26/20 Craig-Hallum
MicroVision downgraded to Hold from Buy at Craig-Hallum
02/26/20 H.C. Wainwright
MicroVision downgraded to Neutral from Buy at H.C. Wainwright
02/26/20 Ladenburg
Ladenburg downgrades MicroVision to Neutral on lost contract
ACB Aurora Cannabis
$12.00 /

+0.22 (+1.87%)

06/24/20
Fly Intel: Top five analyst upgrades
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
06/24/20 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/22/20 CIBC
Aurora Cannabis price target raised to C$24 from C$14 at CIBC
VSTM Verastem
$1.45 /

-0.005 (-0.34%)

04/27/20 JonesTrading
Verastem downgraded to Hold from Buy at JonesTrading
04/23/20 Cantor Fitzgerald
Verastem's market cap could double with positive data, says Cantor Fitzgerald
03/20/20 JonesTrading
Verastem upgraded to Buy from Hold at JonesTrading
03/03/20 Cantor Fitzgerald
Verastem price target raised to $6 from $3 at Cantor Fitzgerald
AXDX Accelerate Diagnostics
$16.81 /

+0.2 (+1.20%)

05/11/20 Piper Sandler
Accelerate Diagnostics price target lowered to $14 from $16 at Piper Sandler
01/14/20 Piper Sandler
Accelerate Diagnostics price target raised to $20 from $16 at Piper Sandler
09/27/19 JPMorgan
JPMorgan downgrades Accelerate Diagnostics to Underweight on estimate risk
09/27/19 JPMorgan
Accelerate Diagnostics downgraded to Underweight from Neutral at JPMorgan
VAL Valaris
$0.60 /

+0.0396 (+7.08%)

BCLI BrainStorm
$13.29 /

+0.14 (+1.06%)

ZYNE Zynerba
$3.78 /

+0.31 (+8.93%)

HTZ Hertz
$1.46 /

+0.01 (+0.69%)

NE Noble Corp.
$0.29 /

+0.0088 (+3.12%)

MVIS MicroVision
$1.50 /

+0.01 (+0.67%)

ACB Aurora Cannabis
$12.00 /

+0.22 (+1.87%)

VSTM Verastem
$1.45 /

-0.005 (-0.34%)

AXDX Accelerate Diagnostics
$16.81 /

+0.2 (+1.20%)

VAL Valaris
$0.60 /

+0.0396 (+7.08%)

ZYNE Zynerba
$3.78 /

+0.31 (+8.93%)

HTZ Hertz
$1.46 /

+0.01 (+0.69%)

NE Noble Corp.
$0.29 /

+0.0088 (+3.12%)

ACB Aurora Cannabis
$12.00 /

+0.22 (+1.87%)

VAL Valaris
$0.60 /

+0.0396 (+7.08%)

ZYNE Zynerba
$3.78 /

+0.31 (+8.93%)

HTZ Hertz
$1.46 /

+0.01 (+0.69%)

NE Noble Corp.
$0.29 /

+0.0088 (+3.12%)

ACB Aurora Cannabis
$12.00 /

+0.22 (+1.87%)

VSTM Verastem
$1.45 /

-0.005 (-0.34%)

AXDX Accelerate Diagnostics
$16.81 /

+0.2 (+1.20%)

VAL Valaris
$0.60 /

+0.0396 (+7.08%)

BCLI BrainStorm
$13.29 /

+0.14 (+1.06%)

ASHR X-trackers Harvest CSI 300
$34.48 /

-0.445 (-1.27%)

HTZ Hertz
$1.46 /

+0.01 (+0.69%)

NE Noble Corp.
$0.29 /

+0.0088 (+3.12%)

MVIS MicroVision
$1.50 /

+0.01 (+0.67%)

ACB Aurora Cannabis
$12.00 /

+0.22 (+1.87%)

VSTM Verastem
$1.45 /

-0.005 (-0.34%)

AXDX Accelerate Diagnostics
$16.81 /

+0.2 (+1.20%)

Hot Stocks
Kandi affiliate Fengsheng Automotive announces release of Maple 30X 'City SUV' » 08:43
07/13/20
07/13
08:43
07/13/20
08:43
KNDI

Kandi Technologies

$4.89 /

+0.125 (+2.63%)

Kandi Technologies Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KNDI Kandi Technologies
$4.89 /

+0.125 (+2.63%)

KNDI Kandi Technologies
$4.89 /

+0.125 (+2.63%)

KNDI Kandi Technologies
$4.89 /

+0.125 (+2.63%)

Upgrade
Greenbrier upgraded to Neutral at Susquehanna » 08:42
07/13/20
07/13
08:42
07/13/20
08:42
GBX

Greenbrier

$25.07 /

+3.325 (+15.29%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

06:49 Today Stephens
Greenbrier price target raised to $25 from $18 at Stephens
06:17 Today Susquehanna
Greenbrier upgraded to Neutral from Negative at Susquehanna
04/28/20 Susquehanna
Greenbrier downgraded to Negative from Neutral at Susquehanna
04/08/20 KeyBanc
Greenbrier price target lowered to $30 from $38 at KeyBanc
GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

Recommendations
Pacira price target raised to $68 from $63 at H.C. Wainwright » 08:42
07/13/20
07/13
08:42
07/13/20
08:42
PCRX

Pacira

$57.84 /

+0.19 (+0.33%)

, JNJ

Johnson & Johnson

$142.45 /

-0.01 (-0.01%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCRX Pacira
$57.84 /

+0.19 (+0.33%)

JNJ Johnson & Johnson
$142.45 /

-0.01 (-0.01%)

PCRX Pacira
$57.84 /

+0.19 (+0.33%)

07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
JNJ Johnson & Johnson
$142.45 /

-0.01 (-0.01%)

07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
PCRX Pacira
$57.84 /

+0.19 (+0.33%)

JNJ Johnson & Johnson
$142.45 /

-0.01 (-0.01%)

JNJ Johnson & Johnson
$142.45 /

-0.01 (-0.01%)

PCRX Pacira
$57.84 /

+0.19 (+0.33%)

JNJ Johnson & Johnson
$142.45 /

-0.01 (-0.01%)

JNJ Johnson & Johnson
$142.45 /

-0.01 (-0.01%)

Recommendations
Universal Technical weakness a buying opportunity, says Lake Street » 08:42
07/13/20
07/13
08:42
07/13/20
08:42
UTI

Universal Technical

$6.30 /

-0.1 (-1.56%)

Lake Street analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UTI Universal Technical
$6.30 /

-0.1 (-1.56%)

UTI Universal Technical
$6.30 /

-0.1 (-1.56%)

06/02/20 Argus
Universal Technical price target lowered to $9 from $12 at Argus
06/02/20 Lake Street
Lake Street more confident in Universal Technical estimates as more labs reopen
04/02/20 Dougherty
Universal Technical initiated with a Buy at Dougherty
03/18/20 Lake Street
Universal Technical shares more than discount COVID-19 risks, says Lake Street
UTI Universal Technical
$6.30 /

-0.1 (-1.56%)

  • 21
    Feb
  • 13
    Dec
Hot Stocks
PepsiCo: Ecommerce a key area to gain market share » 08:42
07/13/20
07/13
08:42
07/13/20
08:42
PEP

PepsiCo

$134.48 /

+1.82 (+1.37%)

Comments taken from Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/01/20 Goldman Sachs
Monster Beverage price target raised to $78 from $70 at Goldman Sachs
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

PEP PepsiCo
$134.48 /

+1.82 (+1.37%)

Hot Stocks
Phathom Pharmaceuticals appoints Todd Branning as CFO » 08:42
07/13/20
07/13
08:42
07/13/20
08:42
PHAT

Phathom Pharmaceuticals

$29.09 /

-1.21 (-3.99%)

, AMRX

Amneal Pharmaceuticals

$4.64 /

+0.29 (+6.67%)

Phathom Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHAT Phathom Pharmaceuticals
$29.09 /

-1.21 (-3.99%)

AMRX Amneal Pharmaceuticals
$4.64 /

+0.29 (+6.67%)

PHAT Phathom Pharmaceuticals
$29.09 /

-1.21 (-3.99%)

06/26/20 Goldman Sachs
Phathom Pharmaceuticals downgraded to Sell from Neutral at Goldman Sachs
11/19/19 Evercore ISI
Phathom Pharmaceuticals initiated with an Outperform at Evercore ISI
11/19/19
Fly Intel: Top five analyst initiations
11/19/19 Needham
Phathom Pharmaceuticals initiated with a Buy at Needham
AMRX Amneal Pharmaceuticals
$4.64 /

+0.29 (+6.67%)

05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral amid generics recovery at Guggenheim
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral from Sell at Guggenheim
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
01/02/20 RBC Capital
Amneal Pharmaceuticals price target raised to $4 from $3 at RBC Capital
PHAT Phathom Pharmaceuticals
$29.09 /

-1.21 (-3.99%)

AMRX Amneal Pharmaceuticals
$4.64 /

+0.29 (+6.67%)

  • 25
    Oct
AMRX Amneal Pharmaceuticals
$4.64 /

+0.29 (+6.67%)

PHAT Phathom Pharmaceuticals
$29.09 /

-1.21 (-3.99%)

Hot Stocks
Relmada Therapeutics approved for uplisting to Nasdaq Global Select Market » 08:41
07/13/20
07/13
08:41
07/13/20
08:41
RLMD

Relmada Therapeutics

$42.08 /

-0.35 (-0.82%)

Relmada Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLMD Relmada Therapeutics
$42.08 /

-0.35 (-0.82%)

RLMD Relmada Therapeutics
$42.08 /

-0.35 (-0.82%)

05/27/20 Goldman Sachs
Goldman says Relmada clearance for Phase 3 supports REL-1017 safety, efficacy
05/04/20 SunTrust
Relmada Therapeutics initiated with a Buy at SunTrust
05/04/20
Fly Intel: Top five analyst initiations
04/21/20 Goldman Sachs
Relmada Therapeutics initiated with a Buy at Goldman Sachs
  • 04
    Dec
Recommendations
Domino's Pizza price target raised to $435 from $415 at RBC Capital » 08:41
07/13/20
07/13
08:41
07/13/20
08:41
DPZ

Domino's Pizza

$398.51 /

+12.91 (+3.35%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DPZ Domino's Pizza
$398.51 /

+12.91 (+3.35%)

DPZ Domino's Pizza
$398.51 /

+12.91 (+3.35%)

07:44 Today BTIG
Domino's Pizza price target raised to $440 from $405 at BTIG
07/10/20 MKM Partners
Domino's Pizza price target raised to $375 from $350 at MKM Partners
07/10/20 Oppenheimer
Domino's Pizza price target raised to $425 from $405 at Oppenheimer
07/06/20 OTR Global
Domino's Pizza upgraded to Positive from Mixed at OTR Global
DPZ Domino's Pizza
$398.51 /

+12.91 (+3.35%)

DPZ Domino's Pizza
$398.51 /

+12.91 (+3.35%)

DPZ Domino's Pizza
$398.51 /

+12.91 (+3.35%)

Hot Stocks
Schmitt Industries Inc to remain listed on Nasdaq » 08:40
07/13/20
07/13
08:40
07/13/20
08:40
SMIT

Schmitt Industries Inc

$3.71 /

+0.265 (+7.70%)

Schmitt Industries, Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMIT Schmitt Industries Inc
$3.71 /

+0.265 (+7.70%)

SMIT Schmitt Industries Inc
$3.71 /

+0.265 (+7.70%)

Hot Stocks
Kearny Financial completes acquisition of MSB Financial » 08:40
07/13/20
07/13
08:40
07/13/20
08:40
KRNY

Kearny Financial

$7.70 /

+0.23 (+3.08%)

, MSBF

MSB Financial

$10.61 /

+0.01 (+0.09%)

Kearny Financial Corp.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRNY Kearny Financial
$7.70 /

+0.23 (+3.08%)

MSBF MSB Financial
$10.61 /

+0.01 (+0.09%)

KRNY Kearny Financial
$7.70 /

+0.23 (+3.08%)

04/06/20 Piper Sandler
Kearny Financial upgraded to Overweight from Neutral at Piper Sandler
01/31/20 Piper Sandler
Kearny Financial downgraded to Neutral from Overweight at Piper Sandler
MSBF MSB Financial
$10.61 /

+0.01 (+0.09%)

KRNY Kearny Financial
$7.70 /

+0.23 (+3.08%)

Hot Stocks
OpGen, Menarini Silicon Biosystems enter co-promotion partnership » 08:39
07/13/20
07/13
08:39
07/13/20
08:39
OPGN

OpGen

$2.15 /

+0.025 (+1.18%)

Menarini Silicon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$2.15 /

+0.025 (+1.18%)

OPGN OpGen
$2.15 /

+0.025 (+1.18%)

06/09/20 Alliance Global Partners
Alliance Global Partners sees OpGen preliminary data as positive
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
OPGN OpGen
$2.15 /

+0.025 (+1.18%)

Hot Stocks
Bellerophon treats first patient in Phase 3 study of INOpulse iNO therapy » 08:38
07/13/20
07/13
08:38
07/13/20
08:38
BLPH

Bellerophon

$12.90 /

-0.05 (-0.39%)

Bellerophon Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLPH Bellerophon
$12.90 /

-0.05 (-0.39%)

BLPH Bellerophon
$12.90 /

-0.05 (-0.39%)

04/14/20
Fly Intel: Top five analyst initiations
04/14/20 Brookline
Bellerophon jumps after Brookline starts with Buy rating, $35 target
04/13/20 Brookline
Bellerophon initiated with a Buy at Brookline
02/18/20 H.C. Wainwright
Bellerophon results pave way for Phase 3 trial, says H.C. Wainwright
BLPH Bellerophon
$12.90 /

-0.05 (-0.39%)

  • 19
    May
BLPH Bellerophon
$12.90 /

-0.05 (-0.39%)

Conference/Events
Analog Devices to host conference call » 08:37
07/13/20
07/13
08:37
07/13/20
08:37
MXIM

Maxim Integrated

$64.10 /

-0.33 (-0.51%)

, ADI

Analog Devices

$124.42 /

+0.14 (+0.11%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

07:10 Today Credit Suisse
Credit Suisse would see an Analog/Maxim Integrated transaction as very positive
04/29/20 Credit Suisse
Maxim Integrated price target lowered to $60 from $68 at Credit Suisse
03/30/20 Citi
Maxim Integrated price target lowered to $52 from $65 at Citi
03/20/20
Fly Intel: Top five analyst initiations
ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

07:10 Today Credit Suisse
Credit Suisse would see an Analog/Maxim Integrated transaction as very positive
06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
05/21/20 Raymond James
Analog Devices price target raised to $125 from $100 at Raymond James
05/21/20 SunTrust
Analog Devices price target raised to $133 from $124 at SunTrust
MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

MXIM Maxim Integrated
$64.10 /

-0.33 (-0.51%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

ADI Analog Devices
$124.42 /

+0.14 (+0.11%)

Recommendations
Rigel's Tavalisse shown effective for COVID lung injury, says Citi » 08:37
07/13/20
07/13
08:37
07/13/20
08:37
RIGL

Rigel Pharmaceuticals

$1.78 /

-0.04 (-2.20%)

A new study out of MIT…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

08:30 Today Citi
Study points to possible role for Rigel in treating COVID injury, says Citi
02/27/20 Piper Sandler
Piper Sandler continues to like Rigel Pharmaceuticals setup
01/16/20 H.C. Wainwright
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
01/13/20 Piper Sandler
Rigel still one of the most under-appreciated stories in sector, says Piper
RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

Hot Stocks
Nexstar transfers option to buy E.W. Scripps' CW affiliate WPIX to Mission » 08:37
07/13/20
07/13
08:37
07/13/20
08:37
NXST

Nexstar

$79.90 /

+3.89 (+5.12%)

, SSP

E.W. Scripps

$8.90 /

+0.69 (+8.40%)

The E.W. Scripps Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXST Nexstar
$79.90 /

+3.89 (+5.12%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

NXST Nexstar
$79.90 /

+3.89 (+5.12%)

06/22/20 Benchmark
Nexstar price target raised to $125 from $120 at Benchmark
05/07/20 Wells Fargo
Nexstar price target raised to $88 from $81 at Wells Fargo
05/07/20 B. Riley FBR
Nexstar price target raised to $115 from $110 at B. Riley FBR
05/05/20 B. Riley FBR
Nexstar price target lowered to $110 from $139 at B. Riley FBR
SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
NXST Nexstar
$79.90 /

+3.89 (+5.12%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

Hot Stocks
Adverum Biotechnologies randomizes first patient in Phase 2 INFINITY trial » 08:36
07/13/20
07/13
08:36
07/13/20
08:36
ADVM

Adverum Biotechnologies

$19.90 /

-1.18 (-5.60%)

Adverum Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

07/08/20 Cantor Fitzgerald
Adverum Biotechnologies price target raised to $36 from $21 at Cantor Fitzgerald
06/29/20 Piper Sandler
Adverum Biotechnologies should be bought on selloff, says Piper Sandler
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/26/20 Raymond James
Adverum Biotechnologies downgraded to Underperform at Raymond James
ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

  • 12
    Feb
ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

Recommendations
Misonix price target raised to $23 from $18 at Craig-Hallum » 08:36
07/13/20
07/13
08:36
07/13/20
08:36
MSON

Misonix

$14.09 /

+3.2 (+29.38%)

Craig-Hallum analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSON Misonix
$14.09 /

+3.2 (+29.38%)

MSON Misonix
$14.09 /

+3.2 (+29.38%)

04/03/20 Craig-Hallum
Misonix price target lowered to $18 from $28 at Craig-Hallum
04/03/20 BTIG
Misonix price target lowered to $18 from $27 at BTIG
12/31/19 Craig-Hallum
Misonix's amended credit line removes capital needs questions, says Craig-Hallum
08/15/19 Canaccord
Misonix price target raised to $30 from $24 at Canaccord
MSON Misonix
$14.09 /

+3.2 (+29.38%)

  • 23
    Jan
Hot Stocks
Wrap Technologies to train seven new agencies on BolaWrap in Maryland » 08:35
07/13/20
07/13
08:35
07/13/20
08:35
WRTC

Wrap Technologies

$12.22 /

-0.11 (-0.89%)

Wrap Technologies is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRTC Wrap Technologies
$12.22 /

-0.11 (-0.89%)

WRTC Wrap Technologies
$12.22 /

-0.11 (-0.89%)

07/06/20 Northland
Wrap Technologies downgraded to Market Perform from Outperform at Northland
03/24/20 Northland
Wrap Technologies upgraded to Outperform from Market Perform at Northland
01/29/20 Ladenburg
Wrap Technologies initiated with a Buy at Ladenburg
01/29/20 Ladenburg
Wrap Technologies initiated with a Buy at Ladenburg
WRTC Wrap Technologies
$12.22 /

-0.11 (-0.89%)

Hot Stocks
Enzo Biochem receives EUA for test system for detection of SARS-CoV-2 » 08:35
07/13/20
07/13
08:35
07/13/20
08:35
ENZ

Enzo Biochem

$2.85 /

+0.15 (+5.56%)

Enzo Biochem announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENZ Enzo Biochem
$2.85 /

+0.15 (+5.56%)

Hot Stocks
T. Rowe Price reports preliminary AUM $1.22T at June 30 » 08:34
07/13/20
07/13
08:34
07/13/20
08:34
TROW

T. Rowe Price

$127.32 /

+4.49 (+3.66%)

Client transfers from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

06/29/20 BMO Capital
T. Rowe Price price target raised to $128 from $109 at BMO Capital
06/15/20 Barclays
T. Rowe Price price target raised to $110 from $100 at Barclays
04/29/20 Wells Fargo
T. Rowe Price price target raised to $125 from $115 at Wells Fargo
04/29/20 BMO Capital
T. Rowe Price price target raised to $92 from $86 at BMO Capital
TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

Hot Stocks
Syneos Health signs service agreement with Pfizer » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
SYNH

Syneos Health

$56.41 /

+0.17 (+0.30%)

, PFE

Pfizer

$33.84 /

+0.39 (+1.17%)

Syneos Health (SYNH)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

04/03/20 Mizuho
Syneos Health price target lowered to $42 from $56 at Mizuho
04/02/20 Credit Suisse
Syneos Health price target lowered to $62 from $72 at Credit Suisse
03/30/20 Goldman Sachs
Syneos Health downgraded to Neutral from Buy at Goldman Sachs
03/17/20 SunTrust
SunTrust cuts price targets across CROs, downgrades MedPace
PFE Pfizer
$33.84 /

+0.39 (+1.17%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

Earnings
Lazydays reports preliminary Q2 revenue $214M, one estimate $181M » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
LAZY

Lazydays

$10.03 /

+1.375 (+15.89%)

Reports preliminary Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAZY Lazydays
$10.03 /

+1.375 (+15.89%)

LAZY Lazydays
$10.03 /

+1.375 (+15.89%)

06/30/20 Craig-Hallum
Lazydays continues geographic expansion with 'sizeable' deal, says Craig-Hallum
06/11/20 Craig-Hallum
Lazydays price target raised to $12 from $7 at Craig-Hallum
06/10/20 Craig-Hallum
Lazydays price target raised to $12 from $7 at Craig-Hallum
LAZY Lazydays
$10.03 /

+1.375 (+15.89%)

Hot Stocks
Net Element amends merger LOI with Mullen to extend exclusivity period » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
NETE

Net Element

$11.54 /

+0.94 (+8.87%)

Net Element provides an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NETE Net Element
$11.54 /

+0.94 (+8.87%)

Hot Stocks
Citi enters alliance with BlackRock for securities services for mutual clients » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
C

Citi

$52.64 /

+3.205 (+6.48%)

, BLK

BlackRock

$554.82 /

+5.27 (+0.96%)

Citi (C) has entered into…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

07/08/20 Seaport Global
Citi initiated with a Buy at Seaport Global
07/07/20 Societe Generale
Societe Generale upgrades BofA, Citi to Buy on 'path to respectability'
07/07/20 Societe Generale
Citi upgraded to Buy from Hold at Societe Generale
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
BLK BlackRock
$554.82 /

+5.27 (+0.96%)

06/15/20 Barclays
BlackRock price target raised to $580 from $515 at Barclays
06/02/20 Wells Fargo
BlackRock price target raised to $605 from $530 at Wells Fargo
05/14/20 Wells Fargo
BlackRock price target raised to $530 from $495 at Wells Fargo
05/12/20 Stephens
PNC Financial upgraded to Overweight from Equal Weight at Stephens
C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

  • 13
    May
C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.